Septerna, Inc. (SEPN), a burgeoning player in the biotechnology sector, is garnering attention from both investors and analysts alike. With a market cap of $1.03 billion,..
Castle Biosciences, Inc. (NASDAQ: CSTL), a key player in the healthcare sector, specializes in molecular diagnostics, offering innovative test solutions for dermatologic cancers and mental health..
For investors with a keen eye on the biotechnology sector, AnaptysBio, Inc. (NASDAQ: ANAB) presents an intriguing opportunity. This San Diego-based clinical-stage company is making strides..
Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA), a pioneer in the field of synthetic biology, operates at the cutting edge of biotechnology. Headquartered in Boston, Massachusetts, the..
Sana Biotechnology, Inc. (NASDAQ: SANA) has captured the interest of investors with its innovative approach to cell engineering and a standout potential upside of 82.99%. Operating..
Zenas BioPharma, Inc. (ZBIO), a clinical-stage biopharmaceutical company, has been capturing significant attention in the biotechnology sector with its focus on transformative immunology-based therapies. Headquartered in..
Tourmaline Bio, Inc. (TRML) is making waves in the healthcare sector, particularly within the biotechnology industry. Based in New York, this clinical-stage company is focused on..
Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector with a focus on medical devices, presents a compelling investment case with a potential..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a biopharmaceutical company specializing in oncology therapies, has caught the attention of investors with a potential upside of 131.48%. This impressive..
ATAI Life Sciences N.V. (NASDAQ: ATAI) is making waves in the biotechnology sector, particularly in the field of mental health treatments. With a market capitalization of..
Kamada Ltd. (NASDAQ: KMDA), an Israeli-based healthcare company in the Drug Manufacturers – Specialty & Generic industry, is capturing investor attention with its significant upside potential...
Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is drawing attention from investors with its significant potential upside of 311.11%, according to current analyst ratings. With..
Stoke Therapeutics, Inc. (NASDAQ: STOK) stands at the forefront of biotechnology innovation with a focus on severe genetic diseases. The company, which emerged in 2014 and..
Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, is garnering attention for its notable potential upside of 34.46%. As a company specializing..
Nutex Health Inc. (NUTX) is making waves in the healthcare sector, particularly within the medical care facilities industry. With its headquarters in Houston, Texas, Nutex Health..
In the ever-evolving landscape of biotechnology, Arbutus Biopharma Corporation (NASDAQ: ABUS) emerges as a noteworthy contender with its focus on innovative therapeutics for infectious diseases. With..
Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, is making waves in the medical care facilities industry. Based in Dallas, Texas, Sonida..
Investors with a keen interest in biotech innovation should keep an eye on REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology firm pioneering gene therapies. With a..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing the attention of investors with its promising pipeline in the biotechnology sector. As a clinical-stage biopharmaceutical company, Oric is..
Prothena Corporation plc (NASDAQ: PRTA), a pioneering biotech entity headquartered in Dublin, Ireland, is making strategic strides in the healthcare sector, specifically within the biotechnology industry...
